Article Text

Download PDFPDF

Original article
Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis
  1. Emma MM Burkitt Wright1,2,
  2. Emma Sach2,
  3. Saba Sharif3,
  4. Oliver Quarrell4,
  5. Thomas Carroll5,
  6. Richard W Whitehouse6,
  7. Meena Upadhyaya7,
  8. Susan M Huson1,2,
  9. D Gareth R Evans1,2
  1. 1Genetic Medicine Research Group, Faculty of Medical and Human Sciences, Institute of Human Development, University of Manchester, Manchester, UK
  2. 2Department of Genetic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
  3. 3West Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, UK
  4. 4Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK
  5. 5Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield, UK
  6. 6Department of Radiology, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
  7. 7Department of Medical Genetics, Cardiff University School of Medicine, Institute of Medical Genetics Building, Cardiff, UK
  1. Correspondence to Professor D Gareth R Evans, Department of Genetic Medicine, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK; gareth.evans{at}cmft.nhs.uk

Abstract

Background Consensus clinical diagnostic criteria for neurofibromatosis type I (NF1) include café-au-lait macules and skinfold freckling. The former are frequently the earliest manifestation of NF1, and as such are of particular significance when assessing young children at risk of the condition. A phenotype of predominantly spinal neurofibromatosis has been identified in a small minority of families with NF1, often in association with a relative or absolute lack of cutaneous manifestations. An association with splicing and missense mutations has previously been reported for spinal neurofibromatosis, but on the basis of molecular results in only a few families.

Method Patients with spinal NF1 were identified through the Manchester nationally commissioned service for complex NF1.

Results Five families with spinal NF1 were identified, with a broad spectrum of NF1 mutations, providing further evidence that this phenotype may arise in association with any genre of mutation in this gene. Pigmentary manifestations were absent or very mild in affected individuals. Several further affected individuals, some with extensive spinal root tumours, were ascertained when additional family members were assessed.

Conclusions Clinical NF1 consensus criteria cannot be used to exclude the diagnosis of spinal NF1, especially in childhood. This emphasises the importance of molecular confirmation in individuals and families with atypical presentations of NF1.

  • Clinical genetics
  • Dermatology
  • Genetics
  • Other neurology

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.